Cargando…

Fulminant type 1 diabetes after COVID-19 vaccination

Detalles Bibliográficos
Autores principales: Tang, Xiaohan, He, Binbin, Liu, Zhenqi, Zhou, Zhiguang, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786596/
https://www.ncbi.nlm.nih.gov/pubmed/35091092
http://dx.doi.org/10.1016/j.diabet.2022.101324
_version_ 1784639145659858944
author Tang, Xiaohan
He, Binbin
Liu, Zhenqi
Zhou, Zhiguang
Li, Xia
author_facet Tang, Xiaohan
He, Binbin
Liu, Zhenqi
Zhou, Zhiguang
Li, Xia
author_sort Tang, Xiaohan
collection PubMed
description
format Online
Article
Text
id pubmed-8786596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-87865962022-01-25 Fulminant type 1 diabetes after COVID-19 vaccination Tang, Xiaohan He, Binbin Liu, Zhenqi Zhou, Zhiguang Li, Xia Diabetes Metab Letters to the Editor Elsevier Masson SAS. 2022-03 2022-01-25 /pmc/articles/PMC8786596/ /pubmed/35091092 http://dx.doi.org/10.1016/j.diabet.2022.101324 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters to the Editor
Tang, Xiaohan
He, Binbin
Liu, Zhenqi
Zhou, Zhiguang
Li, Xia
Fulminant type 1 diabetes after COVID-19 vaccination
title Fulminant type 1 diabetes after COVID-19 vaccination
title_full Fulminant type 1 diabetes after COVID-19 vaccination
title_fullStr Fulminant type 1 diabetes after COVID-19 vaccination
title_full_unstemmed Fulminant type 1 diabetes after COVID-19 vaccination
title_short Fulminant type 1 diabetes after COVID-19 vaccination
title_sort fulminant type 1 diabetes after covid-19 vaccination
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786596/
https://www.ncbi.nlm.nih.gov/pubmed/35091092
http://dx.doi.org/10.1016/j.diabet.2022.101324
work_keys_str_mv AT tangxiaohan fulminanttype1diabetesaftercovid19vaccination
AT hebinbin fulminanttype1diabetesaftercovid19vaccination
AT liuzhenqi fulminanttype1diabetesaftercovid19vaccination
AT zhouzhiguang fulminanttype1diabetesaftercovid19vaccination
AT lixia fulminanttype1diabetesaftercovid19vaccination